75,411 resources
By Version
By Authority
By Realm
Start Prev Rows 13200 - 13400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
|---|---|---|---|---|---|---|---|---|---|
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTRotavirus | IMMZ.D2.DT.Rotavirus | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTRubellaHigh | IMMZ.D2.DT.Rubella.High incidence | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTRubellaLow | IMMZ.D2.DT.Rubella.Low incidence | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTSeasonalinfluenza2Dose | IMMZ.D2.DT.Seasonal influenza | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTBEEnceVir | IMMZ.D2.DT.TBE.EnceVir | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTBEEncepur | IMMZ.D2.DT.TBE.Encepur | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTBEFSME | IMMZ.D2.DT.TBE.FSME-Immun | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTBEMoscow | IMMZ.D2.DT.TBE.TBE-Moscow | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTyphoidTCV | IMMZ.D2.DT.Typhoid.TCV | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTyphoidTy21a | IMMZ.D2.DT.Typhoid.Ty21a | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTTyphoidVIPS | IMMZ.D2.DT.Typhoid.ViPS | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTVaricella1Dose | IMMZ.D2.DT.Varicella.1 dose | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTVaricella2Dose | IMMZ.D2.DT.Varicella.2 doses | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTYellowfever | IMMZ.D2.DT.Yellow fever | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTBCGCI | IMMZ.D5.DT.BCG contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTDTPCI | IMMZ.D5.DT.DTP contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTDengueCI | IMMZ.D5.DT.Dengue contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTHPVCI | IMMZ.D5.DT.HPV contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTHepatitisACI | IMMZ.D5.DT.Hepatitis A contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTHepatitisBCI | IMMZ.D5.DT.Hepatitis B contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTHibCI | IMMZ.D5.DT.Hib contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTJECI | IMMZ.D5.DT.JE contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTMalariaCI | IMMZ.D5.DT.Malaria contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTMeningococcalCI | IMMZ.D5.DT.Meningococcal contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTMumpsCI | IMMZ.D5.DT.Mumps contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTPneumococcalCI | IMMZ.D5.DT.Pneumococcal contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTPolioCI | IMMZ.D5.DT.Polio contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTRabiesCI | IMMZ.D5.DT.Rabies contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTRotavirusCI | IMMZ.D5.DT.Rotavirus contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTRubellaCI | IMMZ.D5.DT.Rubella contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTSeasonalinfluenzaCI | IMMZ.D5.DT.Seasonal influenza contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTTBECI | IMMZ.D5.DT.TBE contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTTyphoidCI | IMMZ.D5.DT.Typhoid contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTVaricellaCI | IMMZ.D5.DT.Varicella contraindications | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTYellowfeverCI | IMMZ.D5.DT.Yellow fever contraindications | draft | 2025-08 | who | |||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT02 | ANC.DT.02 Adolescent HEADSS asessement | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT06 | ANC.DT.06 Physical symptoms and exam results requiring referral | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT32 | ANC.DT.32 Tetanus toxoid-containing vaccination | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT31 | ANC.DT.31 Flu immunization | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT29 | ANC.DT.29 HIV risk counselling | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT28 | ANC.DT.28 Gestational diabetes mellitus (GDM) risk counselling | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT27 | ANC.DT.27 Pre-eclampsia risk counselling | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT17 | ANC.DT.17 Pre-eclampsia, severe pre-eclampsia and hypertension diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT22 | ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT18 | ANC.DT.18 HIV diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT19 | ANC.DT.19 Hepatitis B diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT20 | ANC.DT.20 Hepatitis C diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT21 | ANC.DT.21 Syphilis diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT24 | ANC.DT.24 TB diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT23 | ANC.DT.23 Gestational diabetes mellitus (GDM) and diabetes mellitus (DM) during pregnancy diagnosis | active | 2025-06 | uv | who | ||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTMeaslesSupplementary | IMMZ.D2.DT.Measles.Supplementary dose | draft | 2025-08 | who | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTMeaslesDose0 | IMMZ.D2.DT.Measles.MCV dose 0 | draft | 2025-08 | who | |||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-bodyweight-change-pd | CHFBodyWeightChange | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-bodyweight-pd | CHFBodyWeight | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-jvp-pd | CHFJVPPD | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-net-io-pd | CHFNetIO | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-urine-out-pd | CHFUrineOut | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-creatinine-pd | CHFCreatininePD | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-egfr-pd | CHFEGFRPD | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-o2-sat-pd | CHFO2SatPD | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-potassium-pd | CHFPotassiumPD | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.pharm-quality | R5 | PlanDefinition/plandefinition-drug-pq-ex5-stability-study-protocol | Stability Monitoring Program | active | 2024-05 | uv | hl7 | ||
| hl7.fhir.uv.pharm-quality | R5 | PlanDefinition/plandefinition-drug-pq-ex2-manufacturing-plan | Process 1.0 | active | 2024-05 | uv | hl7 | ||
| hl7.fhir.uv.pharm-quality | R5 | PlanDefinition/plandefinition-drug-pq-ex3-drug-specification | SPECIFICATION(S) FOR DRUG PRODUCT | active | 2024-05 | uv | hl7 | ||
| eng.fhir.profile.dev | R4 | PlanDefinition/esempio-PlanDefinition-ForStrategy | Protocollo per il trattamento del paziente scompensato classificato in classe funzionale NYHA I-II | active | hl7 | ||||
| de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | PlanDefinition/COVID19NonVentilatedPatientsDexamethasoneApplicationPlan | No Dexamethasone Application for non-ventilated COVID-19 patients | active | 2021-12 | uv | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-01 | Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration | draft | 2025-08 | us | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-02 | Recommendation #2 - Opioid Therapy Goals Discussion | draft | 2025-08 | us | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/cpg-common-registration | PlanDefinition - CPG Common Registration | active | 2024-11 | uv | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServiceCreatinineUrine24h | 24-hour urine creatinine panel | active | 2020-02 | ch | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServiceElectrolytesSerum | Blood electrolyte panel (serum or plasma) | active | 2020-02 | ch | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServicePotassiumSerum | Potassium measurement on in vitro blood serum | active | 2023-06 | ch | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-panel-blood-electrolyte | Blood electrolyte panel (serum or plasma) | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-panel-urine24h-creatinine | 24-hour urine creatinine panel | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-potassium-serum | laboratory service - serum potassium level | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.pharm-quality | R5 | PlanDefinition/plandefinition-drug-pq-ex1-validation-protocol | DP PROCESS VALIDATION | active | 2024-05 | uv | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-04-05 | Recommendations #4 and #5 - Lowest Effective Dose | draft | 2025-08 | us | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-rubella-serum | laboratory service - Rubella IgM quantification on serum | draft | 2020-02 | uv | hl7 | ||
| smart.who.int.hiv | R4 | PlanDefinition/HIVD4DT | HIV.D4.DT TB Screening Decision Tables | draft | 2025-07 | who | |||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServiceSodiumSerum | Sodium measurement on in vitro blood serum | active | 2023-06 | ch | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-torch | TORCH (Toxoplasma, Rubella, Cytomegalovirus, Herpes simplex) serology super-panel, acute, on serum | draft | 2020-02 | uv | hl7 | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT25 | ANC.DT.25 Anaemia, iron and folic acid supplementation | active | 2025-06 | uv | who | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/example-lab-panel-urine24h-creatinine-clearance | 24-hour urine creatinine clearance panel | draft | 2020-02 | ch | hl7 | ||
| hl7.fhir.us.ph-library | R4 | PlanDefinition/us-ph-plandefinition-namedEvent-example | US Public Health PlanDefinition NamedEvent Example | active | 2022-06 | us | hl7 | ||
| hl7.fhir.us.ecr | R4 | PlanDefinition/plandefinition-ersd-instance-namedEvent-example | eRSD PlanDefinition Instance NamedEvent Example | active | 2020-12 | us | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServiceCreatinineClearance | Renal Insufficiendy Panel | draft | 2020-02 | ch | hl7 | ||
| hl7.fhir.us.central-cancer-registry-reporting | R4 | PlanDefinition/plandefinition-central-cancer-registry-reporting-example | PlanDefinition Central Cancer Registry Reporting Example | draft | 2020-11 | us | hl7 | ||
| hl7.fhir.us.medmorph-research-dex | R4 | PlanDefinition/plandefinition-example | PlanDefinition Example | draft | 2020-11 | us | hl7 | ||
| hl7.fhir.us.resp-net | R4 | PlanDefinition/plandefinition-example | PlanDefinition RESP-NET Example | active | 2023-06 | us | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabService-eGFR | Renal Insufficiendy Panel: Service eGFR | draft | 2025-01 | ch | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabService-uACR | Renal Insufficiendy Panel uACR | draft | 2025-01 | ch | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServiceRenalInsufficiency | Renal Insufficiency Lab Panel | draft | 2025-01 | ch | hl7 | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCB | ANC.B Routine contact | active | 2021-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCS01 | ANC.S.01 Contact schedule | active | 2021-06 | uv | who | ||
| smart.who.int.hiv | R4 | PlanDefinition/HIV-Testing-PlanDefinition | PlanDefinition - HiV Testing | active | 2025-07 | who | |||
| smart.who.int.hiv | R4 | PlanDefinition/HIV-A-Registration-PlanDefinition | PlanDefinition - HIV.A. Registration | active | 2025-07 | who | |||
| smart.who.int.hiv | R4 | PlanDefinition/CareAndTreatmentClinicalVisit-PlanDefinition | PlanDefinition - Care and treatment clinical visit | active | 2025-07 | who | |||
| smart.who.int.hiv | R4 | PlanDefinition/PrEP-visit-PlanDefinition | PlanDefinition - PrEP Visit | active | 2025-07 | who | |||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-toxoplasma-serum | laboratory service - Toxoplasma gondii Ab panel on serum | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/chf-pathway | CHFPathway | active | 2024-11 | uv | hl7 | ||
| hl7.fhir.uv.cpg | R4 | PlanDefinition/va-ckd-recommendations | VACKDRecommendations | active | 2024-11 | uv | hl7 | ||
| ch.fhir.ig.ch-lab-order | R4 | PlanDefinition/LabServiceVitaminDserum | 25-hydroxyvitamin D3 [Moles/Vol] | active | 2020-02 | ch | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-vitamind-serum | Dosage de la vitamine D dans le sang | draft | 2020-02 | uv | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-06 | Recommendation #6 - Prescribe Lowest Effective Dose and Duration | draft | 2025-08 | us | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-09 | Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions | draft | 2025-08 | us | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-10-order-sign | Recommendation #10 - Urine Drug Testing (order-sign) | draft | 2025-08 | us | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-10-patient-view | Recommendation #10 - Urine Drug Testing (patient-view) | draft | 2025-08 | us | hl7 | ||
| fhir.cdc.opioid-cds-r4 | R4 | PlanDefinition/opioidcds-03 | Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy | draft | 2025-08 | us | hl7 | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT37 | ANC.DT.37 Intimate partner violence (IPV) first-line support and treatment | active | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT36 | ANC.DT.36 Intimate partner violence (IPV) clinical inquiry | active | 2025-06 | uv | who | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-cmv-serum | laboratory service - CMV IgM quantification on serum | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-hsv-serum | laboratory service - HSV 1 & 2 IgM on serum | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-hsvt1-serum | laboratory service - serum HSV 1 IgM titer on serum | draft | 2020-02 | uv | hl7 | ||
| hl7.fhir.uv.order-catalog | R5 | PlanDefinition/example-lab-service-hsvt2-serum | laboratory service - serum HSV 2 IgM titer on serum | draft | 2020-02 | uv | hl7 | ||
| vcds-ig.euvabeco.net | R5 | Questionnaire/example-questionnaire | active | 2025-08 | |||||
| MyHIE.v4-test | R4 | Questionnaire/nhsi-my-core | Malaysia National Health Screening | active | 2023-01 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-02 | Maklumat Adik Beradik | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-03 | Rekod Antenatal Ibu | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-04 | Rekod Kelahiran | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-05 | Senarai Masalah | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-06 | Rawatan Neonatal | active | 2023-10 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-10m | Lawatan Umur 10 Bulan (Sarawak) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-12-15m | Lawatan Umur 12 & 15 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-18-21m | Lawatan Umur 18 & 21 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-1m | Lawatan 1 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-2-3y | (Lawatan Umur 2 Tahun, 2 Tahun 6 Bulan, 3 Tahun & 3 Tahun 6 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-2m | Lawatan umur 2 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-3-4m | Lawatan Umur 3 & 4 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-4y | Lawatan Umur 4 Tahun | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-5-6m | Lawatan Umur 5 & 6 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-5-6y | Lawatan Umur 5 & 6 Tahun | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-9m | Lawatan Umur 9 Bulan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-add | Pemeriksaan Tambahan Lawatan Klinik | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-born | Rekod Baru Lahir | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-ds-0-9m | Pemeriksaan Pergigian (Umur 0-9 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-ds-10-23m | Pemeriksaan Pergigian (Umur 10-23 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-ds-2-4y | Pemeriksaan Pergigian (Umur 2-4 Tahun) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-ds-add | Pemeriksaan Pergigian Tambahan | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-eye | Pemeriksaan Mata | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-madd | Additional Medical Exam for Child | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-mc-18m-3y | Ujian saringan M-CHAT 18 bulan dan 3 tahun | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-md | Rekod 18 Bulan (RME 2) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-md1m | Rekod 1 Bulan (RME 1) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-md4y | Rekod 4 Tahun | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-1-2m | Senarai Semak Rekod Saya Ibu (Lawatan 1 & 2 Bulan) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-12m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 12 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-15m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 15 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-18m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 18 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-2-2y6m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 2 & 2 Tahun 6 Bulan) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-21m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 21 Bulan) | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-3-3y6m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 3 & 3 Tahun 6 Bulan) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-3-4m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 3 & 4 Bulan) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-4y | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 4 Tahun) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-5-6m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 5 & 6 Bulan) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-5-6y | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 5 & 6 Tahun) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-9-10m | Senarai Semak Rekod Saya Ibu Bapa (Lawatan 9 & 10 Bulan) | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-child-rs-carta | Carta Perkembangan Si Comel Anda | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-dengue-checklist | Dengue Assessment Checklist | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-hajj-1 | Personal Details of Hajj Pilgrims | active | 2023-12 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-hajj-12 | Pemeriksaan Kesihatan | active | 2023-12 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-hajj-13 | Diagnosa & Rawatan | active | 2023-12 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-hajj-19 | Personal Details of Hajj Pilgrims | active | 2023-12 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-hajj-6 | Pengakuan Kesihatan Bakal Haji | active | 2023-12 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-01 | Rekod Kesihatan Ibu | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-02 | Perihal Kandungan Lalu | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-03 | Riwayat Kesihatan Ibu Dan Keluarga | active | 2023-09 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-05 | Penyakit/status yang disaring | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-07 | Pemeriksaan Oleh Pegawai Perubatan dan Pegawai Pergigian | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-08 | Senarai Semak Kriteria Untuk Ujian Saringan OGTT | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-09 | Keputusan Ujian OGTT | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-10 | Pemantauan Paras Gula Dalam Darah | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-11 | Pemantauan Tekanan Darah | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-12 | Pemantauan Profil Pre-Eclampsia | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-13 | Pemantauan Peningkatan Berat Badan Ibu Antenatal | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-15 | Keputusan Pemeriksaan Ultrasound | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-21 | Kemasukan Hospital | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-23 | Perihal Kelahiran (Diisi oleh Penyambut Kelahiran) | active | 2023-10 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-24 | Perawatan Postnatal Dirumah | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-25 | Masalah Dikesan Semasa Postnatal, Pengendalian dan Rawatan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-26 | Jadual Suntikan Thromboprophylaxis Untuk Ibu Postnatal ((SUBCUTANEOUS UNFRACTIONATED HEPARIN/ LOW MOLECULAR WEIGHT HEPARIN) - Jika Berkaitan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-27 | Senarai Semak Keberkesanan Penyusuan Susu Ibu Semasa Postnatal | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-28 | Senarai Semak Penjagaan Postnatal Mengikut Kod Warna | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-29 | Pemeriksaan Ibu Postnatal (1 Bulan) di Klinik | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-30 | Rekod Pemberian Pendidikan Kesihatan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-maternal-31 | Informasi Panduan Dan Pendidikan Kesihatan | active | 2023-08 | ||||
| MyHIE.v4-test | R4 | Questionnaire/q-tb-note | TB Clerking Template | active | 2023-09 | ||||
| ca.on.health.sadie | R4 | Questionnaire/9cc3ae17-359c-4df6-be26-01e977b705aa | Activities of Daily Living Index | active | |||||
| ca.on.health.sadie | R4 | Questionnaire/b2e24662-0ee1-4c95-9088-7be895d97c99 | Additional Medical Information | active | |||||
| ca.on.health.sadie | R4 | Questionnaire/17e05ce5-651a-49c9-aecd-c14bc9d4dc23 | Health Status Report | active | |||||
| smart4health.eu.core | R4 | Questionnaire/back-pain-post-training-en.questionnaire | Smart4Health post-training questionnaire | draft | 2020-02 | ||||
| smart4health.eu.core | R4 | Questionnaire/back-pain-pre-training-en.questionnaire | Smart4Health pre-training questionnaire | draft | 2021-04 | ||||
| ca-on-covax.v1 | R4 | Questionnaire/covaxon-questionnaire-consent-client | CovaxonQuestionnaireConsentClient | active | |||||
| ca-on-covax.v1 | R4 | Questionnaire/covaxon-questionnaire-consent-immunization | CovaxonQuestionnaireConsentImmunization | active | |||||
| de.nichtraucherhelden.export | R4 | Questionnaire/Einstellungen | Einstellungen | active | 2021-04 | ||||
| de.nichtraucherhelden.export | R4 | Questionnaire/Motivationsanalyse | Motivationsanalyse | active | 2021-04 | ||||
| de.nichtraucherhelden.export | R4 | Questionnaire/NRHAlternativen | Alternativen | active | 2021-04 | ||||
| de.nichtraucherhelden.export | R4 | Questionnaire/NRHEinstellungen | Einstellungen | active | 2021-04 | ||||
| de.nichtraucherhelden.export | R4 | Questionnaire/NRHMotivationsanalyse | Motivationsanalyse | active | 2021-04 | ||||
| de.nichtraucherhelden.export | R4 | Questionnaire/NRHRituale | Rituale | active | 2021-04 | ||||
| de.nichtraucherhelden.export | R4 | Questionnaire/NRHRueckfallprophylaxe | Rueckfallprophylaxe | active | 2021-04 |